Furthermore, we detected changes in arginine metabolism and showed they have a pivotal role in the pathogenesis of TSC kidney disease associated with overexpression of ASS1, a rate-limiting enzyme in the arginine biosynthetic pathway in a mouse model and human TSC kidneys. The gene discussed is ASS1; the disease is tuberous sclerosis.